Recurrent Vulvovaginal Candidiasis
A Study of Oral VT-1161 for the Treatment of Acute Vaginal Candidiasis (Yeast Infection) in Patients With Recurrent Vaginal Candidiasis
Recurrent Yeast Infection
Study Length: 50 weeks
Target Age/Sex: 18 years and older, Female
Participants will receive at no cost: Study medication and study related procedures. Subject may also receive a stipend for time/travel related to the study.